Stocks to Watch: ICE, NYSE, Bed Bath, RIM

TheStreet.com

NEW YORK -- NYSE Euronext NYX , the operator of the New York Stock Exchange, is in talks to sell itself to rival IntercontinentalExchange ICE , according to reports.

People close to the discussions told The Wall Street Journal an announcement could come as early as Thursday.

Under a deal, ICE would value NYSE at $33 a share, a 37% premium to its closing price on Wednesday, according to a report from CNBC.

NYSE closed Wednesday at $24.05 and soared more than 20% in after-hours trading.


Bed Bath & Beyond BBBY on Wednesday issued forecasts for the fourth quarter and fiscal year that were below analysts' views.

The retailer said it expects fourth-quarter earnings of $1.60 to $1.67 a share, and fiscal-year earnings of $4.48 to $4.54 a share.

Analysts are calling for fourth-quarter earnings of $1.75 a share, and 2012 earnings of $4.62 a share.

Bed Bath & Beyond's board also authorized a new $2.5 billion stock buyback program.

5 Retail Sector Bargains to Buy Before 2013


Jabil Circuit JBL posted fiscal first-quarter earnings on Wednesday that topped Wall Street estimates.

Adjusted earnings for the first quarter were 61 cents a share; analysts forecast profit of 56 cents a share.

Jabil said sales in the quarter rose to $4.64 billion from $4.33 billion a year earlier. Analysts were expecting sales of $4.41 billion.

Stephen Gillett Leaves Sinking-Ship Best Buy for Symantec


Research In Motion RIMM , the BlackBerry maker, is expected by analysts on Thursday to post a fiscal third-quarter loss of 35 cents a share.

RIM, which has steadily been losing market share in the U.S., is banking on reversing its fortunes with BlackBerry 10, the new operating system that will be unveiled at the end of next month.


An experimental therapy from Amicus Therapeutics FOLD and GlaxoSmithKline GSK failed to improve kidney response in Fabry disease patients compared to placebo in a late-stage study, the companies disclosed late Wednesday.

Amicus shares closed Wednesday at $5.77 but fell 55% to $2.60 in after-hours trading.

Amicus Fabry Drug Fails Pivotal Trial


Analysts expect ConAgra Foods CAG on Thursday to report fiscal second-quarter earnings of 55 cents a share on revenue of $3.69 billion.


Discover Financial Services DFS is expected by Wall Street to post fourth-quarter earnings Thursday of $1.11 a share.


-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE. Sign up today to get e-mail alerts before every trade.

Rates

View Comments (0)